TEVA - Teva Pharmaceutical Inds Ltd
This page shows which of the focused investors we track hold TEVA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2024 it was held by 7 managers with an aggregate reported value of $459.91M, which is 0.04% of the combined portfolio.
As of Q4 2024, 7 tracked institutional managers held TEVA (Teva Pharmaceutical Inds Ltd) with an aggregate reported value of $459.91M — 0.04% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades TEVA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2024
- Ticker
- TEVA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 5.58% | Add +530.1% | 8,997,400 | $198.3M |
| 2 | Viking Global Investors - Viking Global Investors | 0.46% | Reduce -14.1% | 6,503,485 | $143.34M |
| 3 | Harry Burn - Sound Shore | 3.47% | Reduce -20.1% | 4,772,712 | $105.19M |
| 4 | David Einhorn - Greenlight Capital | 0.53% | Add +44.2% | 468,550 | $10.33M |
| 5 | Samantha McLemore - Patient Capital Management | 0.10% | - | 100,000 | $2.2M |
| 6 | Lee Ainslie - Maverick Capital | 0.01% | Reduce -79.4% | 14,155 | $311.98K |
| 7 | Bill Miller - Miller Value Partners | 0.10% | - | 10,950 | $241.34K |
Loading holder history for TEVA…